Your browser doesn't support javascript.
loading
Single nucleotide polymorphism (SNP) chromosomal microarray as a diagnostic tool for mucinous tubular and spindle cell carcinoma: A validation study.
Nielson, Kaitlyn J; Rowsey, Ross; Dasari, Surendra; Sukov, William R; Kipp, Benjamin R; Raghunathan, Aditya; Whaley, Rumeal D; Ebare, Kingsley; Stanton, Melissa L; Reynolds, Jordan P; Sharma, Vidit; Thompson, R Houston; Boorjian, Stephen A; Leibovich, Bradley C; Hernandez, Loren Herrera; Jimenez, Rafael E; Cheville, John C; Gupta, Sounak.
Afiliação
  • Nielson KJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA. Electronic address: Nielson.Kaitlyn@mayo.edu.
  • Rowsey R; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA. Electronic address: Rowsey.Ross@mayo.edu.
  • Dasari S; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, 55905, USA. Electronic address: dasari.surendra@mayo.edu.
  • Sukov WR; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA. Electronic address: sukov.william@mayo.edu.
  • Kipp BR; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA. Electronic address: kipp.benjamin@mayo.edu.
  • Raghunathan A; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA. Electronic address: Raghunathan.Aditya@mayo.edu.
  • Whaley RD; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA. Electronic address: Whaley.Rumeal@mayo.edu.
  • Ebare K; The Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ, 85054, USA. Electronic address: Ebare.Kingsley@mayo.edu.
  • Stanton ML; The Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ, 85054, USA. Electronic address: stanton.melissa1@mayo.edu.
  • Reynolds JP; Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL, 32224, USA. Electronic address: reynolds.jordan@mayo.edu.
  • Sharma V; Department of Urology, Mayo Clinic, Rochester, MN, 55905, USA. Electronic address: sharma.vidit@mayo.edu.
  • Thompson RH; Department of Urology, Mayo Clinic, Rochester, MN, 55905, USA. Electronic address: thompson.robert@mayo.edu.
  • Boorjian SA; Department of Urology, Mayo Clinic, Rochester, MN, 55905, USA. Electronic address: boorjian.stephen@mayo.edu.
  • Leibovich BC; Department of Urology, Mayo Clinic, Rochester, MN, 55905, USA. Electronic address: leibovich.bradley@mayo.edu.
  • Hernandez LH; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA. Electronic address: herrerahernandez.loren@mayo.edu.
  • Jimenez RE; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA. Electronic address: jimenez.rafael@mayo.edu.
  • Cheville JC; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA. Electronic address: cheville.john@mayo.edu.
  • Gupta S; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA. Electronic address: gupta.sounak@mayo.edu.
Hum Pathol ; 146: 57-65, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38615998
ABSTRACT
Mucinous tubular and spindle cell carcinoma (MTSCC) shows significant overlap with papillary renal cell carcinoma (PRCC), and harbor recurrent copy-number alterations (CNA). We evaluated 16 RCC with features suggestive of MTSCC using chromosomal microarrays. The cohort was comprised of 8 females and males, each, with an age range of 33-79 years (median, 59), and a tumor size range of 3.4-15.5 cm (median, 5.0). Half the tumors were high-grade (8/16, 50%) with features such as necrosis, marked cytologic atypia, and sarcomatoid differentiation, and 5/16 (31%) were high stage (≥pT3a). Three (of 16, 19%) cases had a predominant (>95%) spindle cell component, whereas 5/16 (31%) were composed of a predominant (>95%) epithelial component. Most cases (12/16, 75%) exhibited a myxoid background and/or extravasated mucin, at least focally. Twelve (of 16, 75%) cases demonstrated CNA diagnostic of MTSCC (losses of chromosomes 1, 4, 6, 8, 9, 13, 14, 15, and 22). In addition, 2 high-grade tumors showed loss of CDKN2A/B, and gain of 1q, respectively, both of which are associated with aggressive behavior. Three (of 16, 19%) cases, demonstrated nonspecific CNA, and did not meet diagnostic criteria for established RCC subtypes. One (of 16, 6%) low-grade epithelial predominant tumor (biopsy) demonstrated characteristic gains of 7, 17, and loss of Y, diagnostic of PRCC. MTSCC can be a morphologically heterogenous tumor. Our study validates the detection of characteristic chromosomal CNA for diagnostic use that may be useful in challenging cases with unusual spindle cell or epithelial predominant features, as well as in high-grade tumors.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma Mucinoso / Polimorfismo de Nucleotídeo Único / Neoplasias Renais Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Hum Pathol Assunto da revista: PATOLOGIA Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma Mucinoso / Polimorfismo de Nucleotídeo Único / Neoplasias Renais Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Hum Pathol Assunto da revista: PATOLOGIA Ano de publicação: 2024 Tipo de documento: Article